Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03688282 · ClinicalTrials.gov registry record · NA
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2
A NA study of Osteopenia, sponsored by Theranova, L.L.C..
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT03688282: Completed NA study of Osteopenia, sponsored by Theranova, L.L.C..
NCT03688282 is a NA study of Osteopenia that has completed, run by Theranova, L.L.C.. The registered enrollment target is 18 participants, below the 110-participant average among 9 other Osteopenia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03688282, a NA study of Osteopenia, has completed, sponsored by Theranova, L.L.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The wearable vibration device aims to consistently deliver vibrations directly to the hip and spine and allowing use during many everyday activities. We propose that demonstrating higher rates of compliance and consistent delivery of optimal force, with accelerometer feedback, will provide a superior alternative to whole body vibration and is plausibly more effective at preventing bone loss in postmenopausal women than vibration platforms in the home setting.
Primary Outcome
Percent change in NTX, a biomarker of bone loss activity measured in the blood. Percent change in NTX was determined from Baseline (pre-treatment) to 30-minutes post-treatment for the sham treatment and the active treatments. The difference in percent change was then compared between active and sham treatments.
Conditions Studied
Interventions
- DEVICE Wearable vibration belt
- DEVICE Sham, wearing belt
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-07-11 |
| Est. Completion | 2019-04-17 |
| Phase | NA |
What the finished NCT03688282 record still lists
NCT03688282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 110-participant average among 9 other Osteopenia trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Osteopenia appearing as the primary indexed condition, and to 2 interventions - of which Wearable vibration belt is the first listed.
NCT03688282 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT03688282 about?
NCT03688282 is a clinical study titled "Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2". The wearable vibration device aims to consistently deliver vibrations directly to the hip and spine and allowing use during many everyday activities. We propose that demonstrating higher rates of compliance and consistent delivery of optimal force, with accelerometer feedback, will provide a superio...
What is the current status of trial NCT03688282?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-07-11. Estimated completion is 2019-04-17.
What conditions does trial NCT03688282 study?
This clinical trial studies the following conditions: Osteopenia.
What interventions are being tested in trial NCT03688282?
The interventions under investigation include: Wearable vibration belt (DEVICE), Sham, wearing belt (DEVICE).
Who is sponsoring clinical trial NCT03688282?
This trial is sponsored by Theranova, L.L.C., which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03688282 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03688282's enrollment target sits among peer trials
18 10th of 9 the lowest of 9 other Osteopenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
-
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
RECRUITING
-
Melatonin and Osteogenic Loading on Osteopenia
ACTIVE NOT RECRUITING · Early Phase 1
-
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
COMPLETED · Phase 4
-
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
COMPLETED · Phase 1
-
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI